Though both deals face considerable antitrust hurdles, most hedge funds and other institutions zeroed in on what could kill Nasdaq's planned tie-up with the NYSE, stressing Nasdaq CEO Robert Greifeld needs to make a strong case he can overcome a tough regulatory review.